Add news
March 2010
April 2010
May 2010June 2010July 2010
August 2010
September 2010October 2010
November 2010
December 2010
January 2011
February 2011March 2011April 2011May 2011June 2011July 2011August 2011September 2011October 2011November 2011December 2011January 2012February 2012March 2012April 2012May 2012June 2012July 2012August 2012September 2012October 2012November 2012December 2012January 2013February 2013March 2013April 2013May 2013June 2013July 2013August 2013September 2013October 2013November 2013December 2013January 2014February 2014March 2014April 2014May 2014June 2014July 2014August 2014September 2014October 2014November 2014December 2014January 2015February 2015March 2015April 2015May 2015June 2015July 2015August 2015September 2015October 2015November 2015December 2015January 2016February 2016March 2016April 2016May 2016June 2016July 2016August 2016September 2016October 2016November 2016December 2016January 2017February 2017March 2017April 2017May 2017June 2017July 2017August 2017September 2017October 2017November 2017December 2017January 2018February 2018March 2018April 2018May 2018June 2018July 2018August 2018September 2018October 2018November 2018December 2018January 2019February 2019March 2019April 2019May 2019June 2019July 2019August 2019September 2019October 2019November 2019December 2019January 2020February 2020March 2020April 2020May 2020June 2020July 2020August 2020September 2020October 2020November 2020
News Every Day |

FDA authorizes first at-home coronavirus test


The Food and Drug Administration has authorized the first prescription at-home coronavirus test, in a long-awaited milestone.

The test, developed by Lucira Health, can be used by people who are at least 14 years old when their health provider suspects they have Covid-19, the FDA said late Tuesday. The test can be used on younger people, but in that case a health care provider must collect the sample.

The test involves swabbing the inside of the nose, placing the swab in a vial and swirling it before putting the vial in a "test unit." The process gives results in 30 minutes or less.

FDA medical device director Jeff Shuren said the test, which can be fully run outside a lab or health care settings, represents a significant step forward.

“Now, more Americans who may have COVID-19 will be able to take immediate action, based on their results, to protect themselves and those around them,” Shuren said.

The agency said that the health care providers of patients who use the test must report the results to public health authorities.

Crunching the numbers: The at-home test was able to correctly identify 94 percent of positive samples and 98 percent of negative samples diagnosed using a more sensitive lab-based test in a study, according to Lucira's instructions for use.

"Excluding samples with very low levels of virus that possibly no longer reflected active infection, Lucira achieved 100% positive percent agreement," the instructions state.

Background: FDA has previously granted emergency authorization for kits that allow people to take a sample in their home and send it to a lab for testing. But a test people can conduct themselves has been elusive.

Lucira is one of several companies that have been working to develop fully at-home tests to relieve pressure on overburdened testing laboratories and quickly identify new infections.

“While COVID-19 diagnostic tests have been authorized for at-home collection, this is the first that can be fully self-administered and provide results at home,” FDA Commissioner Stephen Hahn said.

Some public health experts, including Harvard University epidemiologist Michael Mina, argue widespread at-home testing could help bring the Covid-19 pandemic in the U.S. under control.

“I believe very firmly that if we asked 100 percent of Americans — maybe we wouldn’t get there — to get tested weekly we could do it,” Mina told POLITICO. To cut down on false positives, a second at-home test that uses a different technological approach should be provided to confirm results, he added.

What’s next: It is unclear how fast Lucira will be able to ramp up manufacturing of the newly authorized at-home test. But FDA says it is eager for more at-home tests to be on the market. Lucira’s website states the test is “intended to cost less than $50” and is manufactured in the U.S.

HHS testing czar Brett Giroir said the health department and Pentagon — which have made investments to boost manufacturing of other Covid-19 tests — are prepared to help Lucira "expand their scope and scale."

“We look forward to proactively working with test developers to support the availability of more at-home test options,” Shuren said.




Read also

Ohio beats No. 22 Notre Dame, spoiling Ivey’s Irish debut.

Olympic hopefuls train at Oklahoma City's Riversport Adventures

Big Sean Celebrates Relationship With Jhene Aiko In Heartwarming Post



News, articles, comments, with a minute-by-minute update, now on Today24.pro




Today24.pro — latest news 24/7. You can add your news instantly now — here